Research on sub-lipid particles, like LP(a), will be useful to measure to help reduce patients "residual risk", once LDL is < 70mg/dL.
"A novel genetic study provides the strongest evidence to date that Lp(a) is a causative factor for coronary disease; the results suggest that medications targeting Lp(a) could lower the risk of..."
For complete story visit theheart.org.
http://feedproxy.google.com/~r/Theheartorg/~3/hUUOufRwL5U/1036877.do
Sent from my Verizon Wireless BlackBerry
No comments:
Post a Comment